Medpage Today, December 9, 2011. In a lukewarm endorsement, an FDA advisory panel voted 15-11 that the benefits of controversial drospirenone-containing oral contraceptives outweigh the risk of venous thromboembolism.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
FDA Revokes Avastin Approval for Breast Cancer- Decision Leaves Some Devastated
The Washington Post, November 19, 2011. “The science is clear: Breast cancer patients are more likely to be harmed than helped by Avastin,” said Diana Zuckerman, president of the National Research Center for Women & Families. “The risks of the drug are very substantial and can be fatal, killing patients long before they would otherwise die from the disease. FDA made a scientific decision, and it was absolutely the right decision.”
Read More »FDA Revokes Approval of Avastin for Breast Cancer
Associated Press, November 18, 2011. Dr. Diana Zuckerman, tells AP about the problems with Avastin.
Read More »Lawmakers May Relax FDA Drug Conflict Rules
Reuters, November 1, 2011. Dr. Diana Zuckerman, president of the National Research Center for Women & Families, talks about the need for stronger conflict of interest rules for the FDA.
Read More »Birth-Control Pills Tied to Dangerous Clots: Which Brands?
CBS News, October 27, 2011. Dr. Diana Zuckerman, president of the National Research Center for Women & Families, questions why the FDA approves birth control pills that are less safe and have no benefit compared to drugs already on the market.
Read More »